FDA & Health

Working Group

FDA & Health

Perhaps the single greatest concern for anyone is the safety of that which is introduced into one’s body from food to medications to medical devices. It stands to reason then, that the practitioners who administer and the facilities and methods that deliver such items would also be of great significance. The importance of these matters has led to a vast and complex regulatory framework which has, no doubt, protected Americans from danger but, at what cost? This working group will inspect the rules, regulations, and policies of this intricate framework and evaluate the benefits alongside the burdens.

Featured Experts:

Michael F. Cannon
James C. Capretta
Yevgeniy Feyman
Ryan Hagemann
David A. Hyman (Chair)
Roger D. Klein
Erika Lietzan
Marisa Maleck
Henry I. Miller
Christina Sandefur
The views and opinions expressed are those of the members of the Working Groups in their personal capacities and not in their official capacities